Phosphonate-containing analogs of cholesteryl ester as novel inhibitors of cholesteryl ester transfer protein

被引：5
|
作者：
Pietzonka, T
Damon, R
Russell, M
Wattanasin, S
机构：
[1] SANDOZ PHARMACEUT CORP,SANDOZ RES INST,PRECLIN RES,DEPT ONCOL,E HANOVER,NJ 07936
[2] SANDOZ PHARMACEUT CORP,SANDOZ RES INST,PRECLIN RES,DEPT METAB DIS,E HANOVER,NJ 07936
[3] SANDOZ PHARMA AG,PRECLIN RES,CH-4002 BASEL,SWITZERLAND
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1996年 / 6卷 / 16期
关键词：
D O I：
10.1016/0960-894X(96)00350-2
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of phosphorus-containing analogs of cholesteryl ester have been synthesized as potential inhibitors of cholesteryl ester transfer protein (CETP). The most potent inhibitor, phosphonate 7, represents a novel inhibitor of CETP. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码：1951 / 1954
页数：4
相关论文
共 50 条
  • [21] Cholesteryl ester transfer protein inhibitors: what is their future?
    Ros, E.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 : 55 - 58
  • [22] Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
    Zhang, Meng
    Lei, Dongsheng
    Peng, Bo
    Yang, Mickey
    Zhang, Lei
    Charles, M. Art
    Rye, Kerry-Anne
    Krauss, Ronald M.
    Johns, Douglas G.
    Ren, Gang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2017, 1862 (12): : 1606 - 1617
  • [23] Refocusing on use of cholesteryl ester transfer protein inhibitors
    Kastelein, John J. P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 47N - 52N
  • [24] Cholesteryl ester transfer protein inhibitors: challenges and perspectives
    Filippatos, T. D.
    Klouras, E.
    Barkas, F.
    Elisaf, M.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (08) : 953 - 962
  • [25] Cholesteryl ester transfer protein inhibitors in precision medicine
    Su, Xin
    Li, Guiyang
    Deng, Yingjian
    Chang, Dong
    CLINICA CHIMICA ACTA, 2020, 510 : 733 - 740
  • [26] USE OF FLUORESCENT CHOLESTERYL ESTER MICROEMULSIONS IN CHOLESTERYL ESTER TRANSFER PROTEIN ASSAYS
    BISGAIER, CL
    MINTON, LL
    ESSENBURG, AD
    WHITE, A
    HOMAN, R
    JOURNAL OF LIPID RESEARCH, 1993, 34 (09) : 1625 - 1634
  • [27] Biochemical characterization of cholesteryl ester transfer protein inhibitors
    Ranalletta, Mollie
    Bierilo, Kathleen K.
    Chen, Ying
    Milot, Denise
    Chen, Qing
    Tung, Elaine
    Houde, Caroline
    Elowe, Nadine H.
    Garcia-Calvo, Margarita
    Porter, Gene
    Eveland, Suzanne
    Frantz-Wattley, Betsy
    Kavana, Mike
    Addona, George
    Sinclair, Peter
    Sparrow, Carl
    O'Neill, Edward A.
    Koblan, Ken S.
    Sitlani, Ayesha
    Hubbard, Brian
    Fisher, Timothy S.
    JOURNAL OF LIPID RESEARCH, 2010, 51 (09) : 2739 - 2752
  • [28] Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors
    Eary, C. Todd
    Jones, Zachary S.
    Groneberg, Robert D.
    Burgess, Laurence E.
    Mareska, David A.
    Drew, Mark D.
    Blake, James F.
    Laird, Ellen R.
    Balachari, Devan
    O'Sullivan, Michael
    Allen, Andrew
    Marsh, Vivienne
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (09) : 2608 - 2613
  • [29] TRIACYLGLYCEROL AND CHOLESTERYL ESTER TRANSFER PROTEIN
    不详
    NUTRITION REVIEWS, 1985, 43 (03) : 90 - 92
  • [30] Cholesteryl ester transfer protein and atherogenesis
    Tall, A
    Sharp, D
    Zhong, S
    Hayek, T
    MasucciMagoulas, L
    Rubin, EM
    Breslow, JL
    ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 : 178 - 184
12345